John D. Harkey Jr - Apr 30, 2024 Form 4 Insider Report for ZUORA INC (ZUO)

Role
Director
Signature
/s/ Diana Lorenz as attorney-in-fact for John D. Harkey, Jr.
Stock symbol
ZUO
Transactions as of
Apr 30, 2024
Transactions value $
$0
Form type
4
Date filed
5/2/2024, 04:34 PM
Previous filing
Apr 3, 2024
Next filing
May 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZUO Class A Common Stock Award $0 +40.6K +1352.23% $0.00 43.6K Apr 30, 2024 Direct F1
holding ZUO Class A Common Stock 100K Apr 30, 2024 By Abraxus Trust F2
holding ZUO Class A Common Stock 437K Apr 30, 2024 By JDH Life Sciences, Inc. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects Restricted Stock Units (RSUs) granted on April 30, 2024, upon the appointment of the Reporting Person to Zuora's Board of Directors. Each RSU represents a contingent right to receive one share of Zuora's Class A Common Stock upon settlement. The RSUs will vest and convert into shares of Zuora's Class A Common Stock as to 1/3rd of the total number of RSUs subject to the award on each of April 30, 2025, April 30, 2026, and April 30, 2027, in each case, so long as the Reporting Person continues to provide services to Zuora through such date. The vesting of the RSUs shall accelerate in full upon the consummation of a Corporate Transaction, as defined in Zuora's 2018 Equity Incentive Plan.
F2 Reporting Person is the trustee and sole beneficiary of the Abraxus Trust and may be deemed to have sole voting and dispositive power with regard to the shares held by the Abraxus Trust.
F3 Reporting Person is the president and sole beneficial owner of JDH Life Sciences, Inc., and may be deemed to share voting and dispositive power with regard to the shares held by JDH Life Sciences, Inc., with Scalar Gauge Management, LLC.